Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Condition: Locally Advanced Cervical Cancer Interventions: Drug: Pembrolizumab; Drug: Carboplatin; Drug: Taxol Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials